Ryohei Yamamoto
Directeur/Bestuurslid bij Titan, Inc. (Japan)
Actieve functies van Ryohei Yamamoto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | 01-05-2013 | - |
Loopbaan van Ryohei Yamamoto
Eerdere bekende functies van Ryohei Yamamoto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELLA, INC. | Hoofd Administratief Officier | 21-03-2011 | 13-06-2012 |
| Directeur/Bestuurslid | 01-02-2010 | 24-03-2015 | |
| Investor Relations Contact | 13-06-2012 | 01-03-2013 | |
| Public Communications Contact | 13-06-2012 | 01-03-2013 | |
| Corporate Officer/Principal | 21-03-2011 | 21-03-2011 | |
Tella Pharma, Inc.
 Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Directeur/Bestuurslid | 01-01-2014 | - |
Statistieken
Internationaal
| Japan | 4 |
Operationeel
| Director/Board Member | 3 |
| Chief Administrative Officer | 1 |
| Investor Relations Contact | 1 |
Sectoraal
| Health Technology | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
Tella Pharma, Inc.
Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Health Technology |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Ryohei Yamamoto
- Ervaring
